Weight gain-induced blood pressure elevation

Hypertension

Volumn 35, Issue 5, 2000, Pages 1135-1140

  Masuo, Kazuko ^a   Mikami, Hiroshi ^a   Ogihara, Toshio ^a   Tuck, Michael L ^b  

^a OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Body mass index; Hypertension, obesity; Insulin; Investigative techniques; Leptin; Obesity; Sympathetic nervous system

Indexed keywords

INSULIN; LEPTIN;

ADRENERGIC SYSTEM; ADULT; ARTICLE; BODY MASS; HUMAN; HYPERTENSION; INSULIN BLOOD LEVEL; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; NORADRENALIN BLOOD LEVEL; OBESITY; PRIORITY JOURNAL; PULSE RATE; WEIGHT GAIN;

EID: 0034110536     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.HYP.35.5.1135     Document Type: Article

References (30)

1. Manton KG. The global impact of noncommunicable disease estimates and projections. World Health Stat Q. 1988;41:255-266.
2. Julius S, Gudbrandsson T. Early association of sympathetic overactivity hypertension, insulin resistance, and coronary risk. J Cardiovasc Pharmacol. 1992;20(suppl 8): S40-S48.
3. Collins S, Kuhn CM, Petro AE, Swick AG, Chrunyk BA, Surwit RS. Role of leptin in fat regulation. Nature. 1996;380:677. Letter.
4. Haynes WG, Morgan DA, Walsh SA, Mark AL, Sivitz WI. Leptin increases sympathetic nerve activity to brown adipose tissue and kidney. FASEB J. 1997;11:A4. Letter.
5. Haynes WG, Morgan DA, Walsh SA, Mark AL, Sivitz WI. Receptor mediated regional sympathetic nerve activation by leptin. J Clin Invest. 1997;100:270-278.
6. Shek EW, Brands MW, Hall JE. Chronic leptin infusion increases arterial pressure. Hypertension. 1998;31(pt 2):409-414.
7. Masuo K, Mikami H, Ogihara T, Tuck ML. Sympathetic activity and body mass index contribute to blood pressure levels. Hypertens Res. In press.
8. Masuo K, Mikami H, Ogihara T, Tuck ML. Changes in sympathetic activity and insulin sensitivity during body weight reduction in obese subjects. Am J Hypertens. 1997;10:19A. Abstract.
9. Masuo K, Mikami H, Ogihara T, Tuck ML. Differences in sympathetic activity in obese hypertensives with and without BP reduction caused by body weight reduction. Circulation. 1997;96(suppl I):I-33. Abstract.
10. Narkiewicz K, Somers VK, Mos L, Kato M, Accurso V, Palatini P. An independent relationship between plasma leptin and heart rate in untreated patients with essential hypertension. J Hypertens. 1999;17:245-249.
11. Schorr U, Blaschke K, Turan S, Distler A, Sharma AM. Relationship between angiotensin, leptin, and blood pressure levels in young normotensive men. J Hypertens. 1998;16:1475-1480.
12. Masuo K, Mikami H, Ogihara T, Tuck ML. Metabolic effects on long-term treatments with nifedipine-retard and captopril in young hypertensive patients. Am J Hypertens. 1997;10:600-610.
13. Grassi G, Seravalle G, Cattaneo BM, Bolla GB, Lanfranchi A. Colombo M, Giannattasio C, Brunani A, Cavagnini F, Mancia G. Sympathetic activation in obese normotensive subjects. Hypertension. 1995;25(pt 1):560-563.
14. Rumantir MS, Vaz M, Jennings GL, Collier G, Kaye DM, Seals DR, Wiesner GH, Brunner-La Rocca HP, Esler MD. Neural mechanisms in human obesity-related hypertension. J Hypertens. 1999;17:1-9.
15. Landsberg L. Diet, obesity and hypertension: a hypothesis involving insulin, the sympathetic nervous system, and adaptive thermogenesis. Q J Med. 1986;61:1081-1090.
16. Ferrannini E, Natali A, Capaldo B, Lehtovirta M, Jacob S, Yki-Jarvinen H. Insulin resistance, hyperinsulinemia, and blood pressure: role of age and obesity. Hypertension. 1997;30:1144-1149.
17. Ferrannini E, Buzzigoli G, Bonadonna R, Giorico MA, Oleggini M, Graziadei L, Pedrinelli R, Brandi L, Bevilacqua S. Insulin resistance in essential hypertension. N Engl J Med. 1987;317:350-357.
18. Modan M, Halkin H, Almog S, Lusky A, Eshkol A, Shefi M, Shitrit A, Fuchs Z. Hyperinsulinemia, a link between hypertension obesity and glucose intolerance. J Clin Invest. 1985;75:809-817.
19. Alonso-Galicia M, Brands MW, Zappe DH, Hall JE. Hypertension in obese Zucker rats: role of angiotensin II and adrenergic activity. Hypertension. 1996;28:1047-1054.
20. Meehan WP, Buchanan TA, Hsueh W. Chronic insulin administration elevates blood pressure in rats. Hypertension. 1994;23(pt 2):1012-1017.
21. Anderson EA, Hoffman RP, Balon TW, Sinkey CA, Mark AL. Hyperinsulinemia produces both sympathetic neural activation and vasodilation in normal humans. J Clin Invest. 1991;87:2246-2252.
22. Cleland SJ, Petrie JR, Ueda S, Elliott HL, Connell JMC. Insulin-mediated vasodilation and glucose uptake are functionally linked in humans. Hypertension. 1999;33(pt 2):554-558.
23. Rowe JW, Young JB, Minaker KL, Stevens AL, Pallotta J, Landsberg L. Effects of insulin and glucose infusions on sympathetic nervous system activity in normal man. Diabetes. 1983;30:219-225.
24. Anderson EA, Balon TW, Hoffman RP, Sinkey CA, Mark AL. Insulin increases sympathetic activity but not blood pressure in borderline hypertensive humans. Hypertension. 1992;19:621-627.
25. Gudbjornsdottir S, Elam M, Sellgren J, Anderson EA. Insulin increases forearm vascular resistance in obese, insulin-resistance hypertensives. J Hypertens. 1996;14:91-97.
26. Vollenweider P, Randin D, Tappy L, Jequier E, Nicod P. Scherrer U. Impaired insulin-induced sympathetic neural activation and vasodilation in skeletal muscle in obese humans. J Clin Invest. 1994;93:2365-2371.
27. Masuo K, Mikami H, Ogihara T, Tuck ML. Sympathetic nerve hyperactivity precedes hyperinsulinemia and blood pressure elevation in a young, nonobese Japanese population. Am J Hypertens. 1997;10:77-83.
28. Julius S, Jamerson K. Sympathetics, insulin resistance and coronary risk in hypertension: the "chicken-and-egg" question. J Hypertens. 1994;12:495-502.
29. Mark AL, Correia M, Morgan DA, Shaffer RA, Haynes WG. Obesity-induced hypertension: new concepts from the emerging biology of obesity. Hypertension. 1999;33(pt 2):537-541.
30. Haynes WG, Sivitz WI, Morgan DA, Walsh SA, Mark AL. Sympathetic and cardiorenal actions of leptin. Hypertension. 1997;30(pt 2):619-623.